The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
- Sponsor
- Huashan Hospital
- Study ID
- NCT07369830
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Clostridium butyricum (live) Tablets(Meiya) — BIOLOGICALClostridium butyricum (live) Tablet administered into the dysfunctional intestine for low dose and high dose group, while control group has no intervention
Study Details
This study aims to propose a novel, easy-to-operate intervention strategy that effectively improves defecation function after stoma reversal and to assess its impact on the gut microbiota.The efficacy and safety of antegrade placement of probiotics into the distal deserted intestine during prophylactic stoma to improve bowel function after stoma reversal were evaluated through randomized controlled clinical trials.Observing the changes in gut microbiota during the prophylactic stoma period, the impact of probiotics on the structure of gut microbiota, and exploring the correlation between gut genera and bowel function after stoma reversal.
Key Dates
- First listed
- Jan 27, 2026
- Start date
- Oct 15, 2025
- Status verified
- Jan 2026
- Primary completion
- Mar 30, 2029
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 156 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: high dose groupthe high dose group received interventions (4 Clostridium butyricum (live) Tablets(Meiya), administered into the dysfunctional intestine twice a week) starting 1 week after the ileostomy
- Experimental: low dose groupthe low dose group received interventions (4 Clostridium butyricum (live) Tablets(Meiya), administered into the dysfunctional intestine once a week) starting 1 week after the ileostomy
- No Intervention: control groupthe control group received routine postoperative follow-up
Primary Outcome Measure
Low Anterior Resection Syndrome Score(LARS Score) [ Time Frame: One month after stoma reversal ]
Central Contacts
- LI Zhenyang, Doctor+86-13764030915
- Xiang Jianbin, Doctor+86-13476272860
Find similar trials
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal CancerPHASE1/PHASE2 · Recruiting · Washington University School of Medicine · Boston, Massachusetts
- Exosomes in Rectal CancerRecruiting · University of Kansas Medical Center · Kansas City, Kansas